Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Highly Sensitized Prospective Kidney Transplant Recipients”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04827979
What this trial is testing

Daratumumab and Belatacept for Desensitization

Who this might be right for
Highly Sensitized Prospective Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 19
Testing effectiveness (Phase 2)Study completedNCT01911546
What this trial is testing

Role of Everolimus in Highly Sensitized Patients

Who this might be right for
Highly-sensitized Kidney Transplant Recipients
Joseph Kahwaji, MD, MPH 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05017545
What this trial is testing

Carfilzomib and Belatacept for Desensitization

Who this might be right for
Highly Sensitized Prospective Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 21
Post-approval studies (Phase 4)Study completedNCT03194321
What this trial is testing

Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients

Who this might be right for
End Stage Renal Disease
Cedars-Sinai Medical Center 20

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation